|
SI2173888T1
(sl)
*
|
2007-07-26 |
2017-01-31 |
Uniqure Ip B.V. |
Bakulovirusni vektorji, ki vsebujejo ponavljajoča kodirna zaporedja z različnimi kodonskimi preferencami
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
EP2545165B1
(en)
|
2010-03-11 |
2020-07-29 |
uniQure IP B.V. |
Mutated rep encoding sequences for use in aav production
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
IT1400425B1
(it)
|
2010-06-08 |
2013-05-31 |
Amsterdam Molecular Therapeutics Bv |
Modified snrnas for use in therapy.
|
|
WO2012145509A2
(en)
|
2011-04-19 |
2012-10-26 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors, and viruses
|
|
GB201210357D0
(en)
|
2012-06-12 |
2012-07-25 |
Ucl Business Plc |
Factor VIII sequences
|
|
WO2015060722A1
(en)
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
|
EP4450630A3
(en)
*
|
2014-03-10 |
2025-01-29 |
uniQure IP B.V. |
Further improved aav vectors produced in insect cells
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
CN107106689A
(zh)
|
2014-11-05 |
2017-08-29 |
沃雅戈治疗公司 |
用于治疗帕金森病的aadc多核苷酸
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
IL292999A
(en)
|
2014-11-14 |
2022-07-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
CN112410338A
(zh)
|
2014-11-14 |
2021-02-26 |
沃雅戈治疗公司 |
调节性多核苷酸
|
|
BR112017011217A2
(pt)
|
2014-11-28 |
2018-02-06 |
Uniqure Ip B.V. |
impurezas de dna em uma composição compreendendo um vírion parvoviral
|
|
WO2016094783A1
(en)
|
2014-12-12 |
2016-06-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
EP3237618B1
(en)
|
2014-12-24 |
2019-05-22 |
uniQure IP B.V. |
Rnai induced huntingtin gene suppression
|
|
AU2017254652B2
(en)
*
|
2016-04-21 |
2022-12-01 |
Virovek, Inc. |
AAV production in insect cells, methods and compositions therefor
|
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017189964A2
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
SG11201809699XA
(en)
|
2016-05-18 |
2018-12-28 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
|
KR20220108216A
(ko)
|
2016-05-18 |
2022-08-02 |
보이저 테라퓨틱스, 인크. |
헌팅톤 질환을 치료하기 위한 조성물 및 방법
|
|
AU2017301600B2
(en)
|
2016-07-26 |
2022-08-04 |
Biomarin Pharmaceutical Inc. |
Novel adeno-associated virus capsid proteins
|
|
EP3510161A4
(en)
|
2016-08-23 |
2020-04-22 |
Akouos, Inc. |
COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON
|
|
CN110650673B
(zh)
|
2016-08-30 |
2024-04-09 |
加利福尼亚大学董事会 |
用于生物医学靶向和递送的方法以及用于实践该方法的装置和系统
|
|
WO2018109207A1
(en)
|
2016-12-16 |
2018-06-21 |
Uniqure Ip B.V. |
Immunoadsorption
|
|
JP2020518259A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ハンチントン病治療組成物および方法
|
|
SG11201909870SA
(en)
|
2017-05-05 |
2019-11-28 |
Voyager Therapeutics Inc |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
KR20240170979A
(ko)
|
2017-07-10 |
2024-12-05 |
유니큐어 아이피 비.브이. |
인간에서의 ａａｖ 유전자 요법을 위한 수단 및 방법
|
|
JP7229989B2
(ja)
|
2017-07-17 |
2023-02-28 |
ボイジャー セラピューティクス インコーポレイテッド |
軌道アレイガイドシステム
|
|
TWI832036B
(zh)
|
2017-08-03 |
2024-02-11 |
美商航海家醫療公司 |
用於aav之遞送之組合物及方法
|
|
MX2020003042A
(es)
|
2017-09-29 |
2020-11-18 |
Voyager Therapeutics Inc |
Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
|
|
EP4454654A3
(en)
|
2017-10-16 |
2025-02-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
US11434502B2
(en)
|
2017-10-16 |
2022-09-06 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (ALS)
|
|
CA3084452A1
(en)
|
2017-12-29 |
2019-07-04 |
Uniqure Ip B.V. |
Modified viral vectors and methods of making and using the same
|
|
RS64499B1
(sr)
|
2018-01-17 |
2023-09-29 |
Meiragtx Uk Ii Ltd |
Modifikovani protein kapsida raav za gensku terapiju
|
|
GB201800903D0
(en)
|
2018-01-19 |
2018-03-07 |
Oxford Genetics Ltd |
Vectors
|
|
EP3794126A1
(en)
|
2018-05-15 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of parkinson's disease
|
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
WO2019241486A1
(en)
|
2018-06-13 |
2019-12-19 |
Voyager Therapeutics, Inc. |
Engineered 5' untranslated regions (5' utr) for aav production
|
|
CA3103963A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
JP2021530548A
(ja)
|
2018-07-24 |
2021-11-11 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics, Inc. |
遺伝子治療製剤を生産するための系および方法
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
EP3850098A1
(en)
|
2018-09-12 |
2021-07-21 |
uniQure IP B.V. |
Rnai induced c9orf72 suppression for the treatment of als/ftd
|
|
US20220125073A1
(en)
*
|
2018-09-20 |
2022-04-28 |
Tallgrass Biologics L.L.C. |
Treatment and control of colony collapse disorder
|
|
CN109295172A
(zh)
*
|
2018-09-26 |
2019-02-01 |
浙江海洋大学 |
大黄鱼清道夫受体家族基因的密码子偏好性分析方法
|
|
CN113383010B
(zh)
|
2018-09-28 |
2025-09-09 |
沃雅戈治疗公司 |
具有经工程化改造的启动子的共济蛋白表达构建体及其使用方法
|
|
TW202035689A
(zh)
|
2018-10-04 |
2020-10-01 |
美商航海家醫療公司 |
測量病毒載體粒子的效價及強度之方法
|
|
JP2022512621A
(ja)
|
2018-10-05 |
2022-02-07 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖ産生タンパク質をコードする操作された核酸コンストラクト
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
EP3867389A1
(en)
|
2018-10-15 |
2021-08-25 |
Voyager Therapeutics, Inc. |
Expression vectors for large-scale production of raav in the baculovirus/sf9 system
|
|
WO2020104435A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
A companion diagnostic to monitor the effects of gene therapy
|
|
EP3883582A1
(en)
|
2018-11-19 |
2021-09-29 |
uniQure IP B.V. |
Method and means to deliver mirna to target cells
|
|
US20200199625A1
(en)
|
2018-11-19 |
2020-06-25 |
Uniqure Ip B.V. |
RNAi induced reduction of ataxin-3 for the treatment of Spinocerebellar ataxia type 3
|
|
WO2020104480A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
|
|
MX2021008542A
(es)
|
2019-01-18 |
2021-11-12 |
Voyager Therapeutics Inc |
Métodos y sistemas para la producción de partículas de aav.
|
|
WO2020223274A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
KR20220081971A
(ko)
|
2019-07-15 |
2022-06-16 |
메이라지티엑스 유케이 Ii 리미티드 |
관절염 질환 치료용 변형된 aav 캡시드 단백질
|
|
US20220290182A1
(en)
|
2019-08-09 |
2022-09-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2021041375A1
(en)
*
|
2019-08-26 |
2021-03-04 |
Rootpath Genomics, Inc. |
Compositions and methods for producing adeno-associated viral vectors
|
|
WO2021041485A1
(en)
|
2019-08-26 |
2021-03-04 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2021053018A1
(en)
|
2019-09-16 |
2021-03-25 |
Uniqure Ip B.V. |
Targeting misspliced transcripts in genetic disorders
|
|
US20230020565A1
(en)
*
|
2019-12-04 |
2023-01-19 |
Sangamo Therapeutics, Inc. |
Novel compositions and methods for producing recombinant aav
|
|
CN116096905A
(zh)
|
2020-02-21 |
2023-05-09 |
阿库斯股份有限公司 |
用于治疗人受试者的非年龄相关性听力损伤的组合物和方法
|
|
WO2021195491A2
(en)
*
|
2020-03-26 |
2021-09-30 |
Asklepios Biopharmaceutical, Inc. |
Inducible promoter for viral vector production
|
|
KR20220161297A
(ko)
*
|
2020-04-02 |
2022-12-06 |
유니큐어 바이오파마 비.브이. |
신규 세포주
|
|
WO2021198508A1
(en)
|
2020-04-02 |
2021-10-07 |
Uniqure Biopharma B.V. |
Dual bifunctional vectors for aav production
|
|
CA3174872A1
(en)
|
2020-04-07 |
2021-10-14 |
Sander Jan Hendrik Van Deventer |
Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereof
|
|
BR112022020753A2
(pt)
|
2020-04-15 |
2022-12-20 |
Voyager Therapeutics Inc |
Compostos de ligação a tau
|
|
BR112023001456A2
(pt)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
|
|
US20230285596A1
(en)
|
2020-07-27 |
2023-09-14 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4301768A2
(en)
|
2021-03-03 |
2024-01-10 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
CN115427561B
(zh)
|
2021-03-09 |
2024-06-04 |
辉大(上海)生物科技有限公司 |
工程化CRISPR/Cas13系统及其用途
|
|
WO2022214635A1
(en)
|
2021-04-08 |
2022-10-13 |
Stichting Vu |
Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
|
|
AU2022285138A1
(en)
|
2021-06-02 |
2023-11-30 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors modified to bind high-density lipoprotein
|
|
WO2022253955A2
(en)
|
2021-06-02 |
2022-12-08 |
Uniqure Biopharma B.V. |
Insect cell production of parvoviral vectors with modified capsid proteins
|
|
WO2022268811A1
(en)
|
2021-06-21 |
2022-12-29 |
Uniqure Biopharma B.V. |
Improved lysis procedures
|
|
US20250382611A1
(en)
|
2021-06-21 |
2025-12-18 |
Uniqure Biopharma B.V. |
Gene constructs for silencing alpha-synuclein and uses thereof
|
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
|
MX2024001329A
(es)
*
|
2021-07-28 |
2024-04-18 |
Biomarin Pharm Inc |
Sistemas de produccion de virus adenoasociados a gran escala.
|
|
CN117716044A
(zh)
*
|
2021-07-28 |
2024-03-15 |
生物马林药物股份有限公司 |
大规模腺相关病毒生产系统
|
|
EP4392434A1
(en)
|
2021-08-26 |
2024-07-03 |
uniQure biopharma B.V. |
Insect cell-produced high potency aav vectors with cns-tropism
|
|
US20250049955A1
(en)
|
2021-11-17 |
2025-02-13 |
Voyager Therapeutics, Inc. |
Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
US20250346920A1
(en)
|
2022-01-25 |
2025-11-13 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
CN114703203B
(zh)
*
|
2022-02-11 |
2024-08-06 |
上海渤因生物科技有限公司 |
杆状病毒载体及其用途
|
|
CN119032174A
(zh)
|
2022-04-12 |
2024-11-26 |
优尼科生物制药有限公司 |
ApoE的核酸调节
|
|
WO2023198702A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of c9orf72
|
|
US20250230437A1
(en)
|
2022-04-12 |
2025-07-17 |
Uniqure Biopharma B.V. |
Novel systems for nucleic acid regulation
|
|
JP2025512061A
(ja)
|
2022-04-12 |
2025-04-16 |
ユニキュアー バイオファーマ ビー．ブイ． |
Ｓｎｃａの核酸調節
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
US20260085328A1
(en)
|
2022-09-08 |
2026-03-26 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4644556A4
(en)
|
2022-12-28 |
2026-04-08 |
Fujifilm Corp |
PROCESS FOR PRODUCING ADENE-ASSOCIATED VIRUS, AND VECTOR SET
|
|
AU2023427408A1
(en)
|
2023-02-02 |
2025-09-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
AU2024256392A1
(en)
|
2023-04-18 |
2025-10-23 |
Uniqure Biopharma B.V. |
Gene delivery vehicles comprising rna and antibodies
|
|
CN121358754A
(zh)
|
2023-04-18 |
2026-01-16 |
优尼科生物制药有限公司 |
具有外周器官去靶向性的新型嗜神经性腺相关病毒衣壳
|
|
EP4698553A1
(en)
|
2023-04-18 |
2026-02-25 |
uniQure biopharma B.V. |
Generation of adeno-associated virus capsid libraries for insect cells
|
|
TW202449167A
(zh)
|
2023-04-26 |
2024-12-16 |
美商航海家醫療公司 |
用於治療肌肉萎縮性脊髓側索硬化症之組成物及方法
|
|
EP4731267A1
(en)
|
2023-06-23 |
2026-04-29 |
uniQure biopharma B.V. |
Novel fragile x constructs
|
|
AU2024332181A1
(en)
|
2023-08-31 |
2026-02-12 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2025051805A1
(en)
|
2023-09-04 |
2025-03-13 |
Uniqure Biopharma B.V. |
Novel neurotropic recombinant adeno-associated virus particles
|
|
AU2024360616A1
(en)
|
2023-10-11 |
2026-04-23 |
Uniqure Biopharma B.V. |
Novel nucleic acid regulation of huntingtin gene
|
|
AU2024357870A1
(en)
|
2023-10-11 |
2026-04-23 |
Uniqure Biopharma B.V. |
Further novel systems for nucleic acid regulation
|
|
AU2024358914A1
(en)
|
2023-10-11 |
2026-04-23 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of msh3 in repeat expansion disorders
|
|
WO2025114524A1
(en)
|
2023-11-30 |
2025-06-05 |
Uniqure Biopharma B.V. |
Formulations for viral drug products
|
|
TW202545971A
(zh)
|
2024-02-08 |
2025-12-01 |
美商戴諾治療公司 |
殼體多肽及其使用方法
|
|
WO2025219443A1
(en)
|
2024-04-19 |
2025-10-23 |
Uniqure Biopharma B.V. |
Nucleic acid for a1at regulation
|
|
US20260125704A1
(en)
|
2024-08-22 |
2026-05-07 |
Uniqure Biopharma B.V. |
rAAV capsids
|
|
WO2026041788A1
(en)
|
2024-08-22 |
2026-02-26 |
Uniqure Biopharma B.V |
Novel bbb interacting capsids
|
|
WO2026064444A1
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064442A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064428A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|